TY  - JOUR 
AU  - López-Muñoz, F.
AU  - García-García, P.
AU  - Álamo González, C
PY  - 2014
SN  - 1734-8803
UR  - http://hdl.handle.net/20.500.12020/764
AB  - The majority of patients with bipolar disorder spend a lot of time in depressive episodes that impose a great burden on patients, caregivers, and society and accounts for the largest part of the morbidity-mortality of the illness. Lurasidone is an...
LA  - en
PB  - Taylor & Francis
TI  - The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder
DO  - 10.1586/14737175.2014.915741
T2  - Expert Review of Neurotherapeutics
M2  - 593
KW  - Adjunctive therapy
KW  - Atypical antipsychotics
KW  - Bipolar disorder
KW  - Lithium
KW  - Lurasidone
KW  - Valproate
VL  - 14
ER  -